The effect of renal failure on the disposition and neuromuscular blocking action of pancuronium bromide

No abstract is available for this paper.

• Publication year

  1977

• Venue

  European Journal of Clinical Pharmacology

• Publication date

  1977-08-17

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/BF00561401PMID 332502
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical pharmacokinetics of pancuronium bromide

  1976cited by this paper
• Pancuronium binding by serum proteins

  1976cited by this paper
• Pharmacokinetics of pancuronium in patients with normal and impaired renal function.

  1976cited by this paper
• Renal failure and postoperative respiratory failure: recurarization?

  1976cited by this paper
• [The metabolism of pancuronium in man].

  1975cited by this paper
• Renal failure and the action of drugs.

  1974cited by this paper
• Renal failure and the action of drugs.

  1974cited by this paper
• Anaesthesia and renal transplantation: an analysis of fifty-six cases.

  1974cited by this paper
• Determination of pancuronium bromide and its metabolites in human urine by dye-extraction method--relation between the extractability and structure of quaternary ammonium ions.

  1974cited by this paper
• The Effect of Renal Failure and Hyperkalemia on the Duration of Pancuronium Neuromuscular Blockade in Man

  1973cited by this paper
• The use of pancuronium bromide in operations for renal insufficiency. Case reports.

  1973cited by this paper
• The Fate of Pancuronium Bromide in Man

  1973cited by this paper
• Fluorimetric and chromatographic determination of pancuronium bromide and its metabolites in biological materials.

  1973cited by this paper
• INFLUENCE OF DISEASE ON BINDING OF DRUGS TO PLASMA PROTEINS *

  1973cited by this paper
• THE USE OF PANCURONIUM BROMIDE IN OPERATIONS FOR RENAL INSUFFICIENCY

  1972cited by this paper
• Prolonged curarization in a patient with renal failure. Case report.

  1972cited by this paper
• The Use of Muscle Relaxants in Anephric Patients

  1972cited by this paper
• Tubocurarine and renal failure.

  1972cited by this paper
• Untoward results of gallamine administration during bilateral nephrectomy: treatment with haemodialysis. Case reports.

  1971cited by this paper
• PROLONGED CURARIZATION IN A PATIENT WITH RENAL FAILURE

  1971cited by this paper
• The Excretion of Gallamine in the Dog

  1969cited by this paper
• The muscle relaxants and renal excretion.

  1967cited by this paper
• The Metabolism and Elimination of d-Tubocurarine-H3

  1967cited by this paper
• Comparison of Electrical and Mechanical Recording of Spontaneous and Evoked Muscle Activity: The Clinical Value of Continuous Recording as an Aid to the Rational Use of Muscle Relaxants During Anesthesia

  1965cited by this paper
• PROLONGED PARESIS FOLLOWING GALLAMINE

  1964cited by this paper
• PROLONGED PARESIS FOLLOWING GALLAMINE; A CASE REPORT.

  1963cited by this paper

• Navigating Anesthesia: Muscle Relaxants and Reversal Agents in Patients with Renal Impairment

  2024cites this paper
• Neuromuscular Blockers and Reversal Drugs

  2019cites this paper
• On Dr Dick Climie and Dr Jack Thomas, and the Genesis of Chemical-Clinical Pharmacology in Australian Anaesthesia Research

  2018cites this paper
• Anesthesia and Intraoperative Management of Renal Transplantation

  2017cites this paper
• Anesthetic pharmacology for kidney transplantation.

  2015cites this paper
• Pharmacology of Muscle Relaxants and Their Antagonists

  2010cites this paper
• Neuromuscular blocking drugs and their antagonists in patients with organ disease

  2009cites this paper
• Clinical pharmacokinetics and pharmacodynamics of fazadinium in renal failure

  2004influential citation
• POST-ANAESTHETIC APNOEA : AN EVENT OF THE PAST?

  1998cites this paper
• Double-blind, randomized, multicenter study of doxacurium vs. pancuronium in intensive care unit patients who require neuromuscular-blocking agents.

  1995cites this paper
• Pharmacokinetics of rocuronium bromide (ORG 9426) in patients with normal renal function or patients undergoing cadaver renal transplantation.

  1992cites this paper
• Neuromuscular blocking drugs and renal failure.

  1992cites this paper
• Clinical Pharmacokinetics of Neuromuscular Blocking Drugs

  1992cites this paper
• Resistance to non-depolarizing neuromuscular blocking agents.

  1991cites this paper
• Anaesthesia for renal transplantation in sickle cell disease

  1990cites this paper
• Inhibition of histamine N-methyltransferase (HNMT) in vitro by neuromuscular relaxants.

  1990cites this paper
• Guide to Drug Dosage in Renal Failure

  1988cites this paper
• The contribution of pharmacokinetics and pharmacodynamics to clinical anaesthesia care

  1988cites this paper
• Atracurium, vecuronium and pancuronium in end-stage renal failure. Dose-response properties and interactions with azathioprine.

  1987cites this paper
• Influence of renal and hepatic function on pharmacodynamics and pharmacokinetics of non-depolarizing muscle relaxants

  1987cites this paper
• Pharmacokinetics of the nondepolarizing neuromuscular relaxants applied to calculation of bolus and infusion dosage regimens.

  1986cites this paper
• Potentiation of the Combination of Pancuronium and Metocurine by Halothane and Isoflurane in Humans with and without Renal Failure

  1985cites this paper
• Use of alcuronium in patients undergoing renal transplantation.

  1984cites this paper
• Vecuronium in renal failure

  1984cites this paper
• Pharmacokinetics and Pharmacodynamics of Vecuronium (ORG NC45) and Pancuronium in Anesthetized Humans

  1983cites this paper
• PHARMACOKINETICS IN RENAL FAILURE

  1983cites this paper
• Plasma Binding of Pancuronium: Effects of Age, Sex, and Disease

  1983cites this paper
• Neuromuscular blocking drugs

  1983cites this paper
• Drug prescribing in renal failure: dosing guidelines for adults.

  1983cites this paper
• Antagonism of neuromuscular blockade.

  1982cites this paper
• Antagonism of pancuronium in renal failure: no recurarization.

  1982cites this paper
• Renal and Biliary Elimination of Vecuronium (ORG NC 45) and Pancuronium in Rats

  1982cites this paper
• Pharmacokinetics of competitive muscle relaxants.

  1982cites this paper
• Clinical Pharmacokinetics of the Non-depolarising Muscle Relaxants

  1981cites this paper
• Pharmacokinetics of edrophonium in anephric and renal transplant patients.

  1981cites this paper
• Pharmacokinetics and Pharmacodynamics of Metocurine in Humans with and without Renal Failure

  1981cites this paper
• Pharmacokinetics of Org NC45 (norcuron) in patients with and without renal failure.

  1981cites this paper
• Tubocurarine and Pancuronium: A Pharmacokinetic View

  1980cites this paper
• Pyridostigmine kinetics with and without renal function

  1980cites this paper
• [Influence of disease on the metabolism and effects of drugs in man].

  1980cites this paper
• Drug therapy in renal failure: dosing guidelines for adults. Part II: sedatives, hypnotics, and tranquilizers; cardiovascular, antihypertensive, and diuretic agents; miscellaneous agents.

  1980cites this paper
• Pharmacokinetics of fazadinium in patients with renal failure.

  1979cites this paper
• Renal Function and the Pharmacokinetics of Neostigmine in Anesthetized Man

  1979cites this paper
• Dose–Response and Plasma Concentration–Response Relationships of Pancuronium in Man

  1979cites this paper
• Disposition kinetics of pancuronium bromide in patients with total biliary obstruction.

  1978cites this paper
• Combined i.v. bolus and infusion of pancuronium bromide.

  1978cites this paper
• FACTORS LIMITING THE RATE OF TERMINATION OF THE NEUROMUSCULAR BLOCKING ACTION OF FAZADINIUM DIBROMIDE

  1978cites this paper
• Plasma levels of pancuronium as a determinant of neuromuscular response in man [proceedings].

  1978cites this paper